European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of patients with pathogenic ACTA2 variants. https://t.co/psSOnmeEyT #inheritedheartdiseases #cardiotwitter
European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of patients with pathogenic ACTA2 variants. https://t.co/JYGFC0T8qZ #inheritedheartdiseases #cardiotwitter
RT @DrMaiteTome: European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of pa…
European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of patients with pathogenic ACTA... - PubMed - NCBI https://t.co/AK6tbX3xqn
European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of patients with pathogenic AC... https://t.co/VqUX52VNpG #hvhebron #cardio [Text complet] @ojrarediseases
RT @inesernando: Good to see @liseurordis listed among the co-authors of this consensus statement #patientengagement #ERNs @vascern https:/…
European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of patients with pathogenic ACTA2 variants. https://t.co/dG5TNtKk8p
RT @LinneaBaudhuin: Recommendations for screening and management of patients with pathogenic ACTA2 variants by @judbacke @robert_leema…
RT @LinneaBaudhuin: Recommendations for screening and management of patients with pathogenic ACTA2 variants by @judbacke @robert_leema…
RT @F101Genomes: European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of pa…
Recommendations for screening and management of patients with pathogenic ACTA2 variants by @judbacke @robert_leema and others. #Genetics #Genomics #GCChat #CardioGen #medtwitter @kate_kotzer https://t.co/Qp0Nn4Gtxn
Good to see @liseurordis listed among the co-authors of this consensus statement #patientengagement #ERNs @vascern
European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of patients with pathogenic ACTA2 variants | Orphanet Journal of Rare Diseases | Full Text https://t.co/KhtsqB7pta